Anti-CD137 Cancer Immunotherapy Suppresses Tumor Growth-Letter
10.1158/0008-5472.CAN-17-2997
Saved in:
Main Authors: | Dharmadhikari, Bhushan, Zeng, Qun, Wu, Meihui, Schwarz, Herbert |
---|---|
Other Authors: | PHYSIOLOGY |
Format: | Letter |
Language: | English |
Published: |
AMER ASSOC CANCER RESEARCH
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/239111 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
CD137 ligand interacts with CD32a to trigger reverse CD137 ligand signaling
by: Zeng, Qun, et al.
Published: (2023) -
CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8(+) T cells to Tc1 phenotype
by: Dharmadhikari, Bhushan, et al.
Published: (2023) -
Regulatory T Cells Inhibit T Cell Activity by Downregulating CD137 Ligand via CD137 Trogocytosis
by: Luu, Khang, et al.
Published: (2023) -
Induction of CD137 expression by viral genes reduces T cell costimulation
by: Wu, Meihui, et al.
Published: (2023) -
ROLE OF CD137-CD137L INTERACTION IN MICROGLIA-MEDIATED IMMUNE RESPONSE
by: NUR SHARALYN BINTE ABDULLAH
Published: (2016)